Intrinsic Value of S&P & Nasdaq Contact Us

Avant Brands Inc. AVTBF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Avant Brands Inc. (AVTBF) , forward earnings yield 769.23%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 0.1

Overall SharesGrow Score: 22/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
24/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AVTBF

Valuation Multiples
P/E (TTM)0.0
Forward P/E0.1
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.14
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.88
Forward EPS (Est.)$3.56
Book Value / Share$0.00
Revenue / Share$3.21
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield769.23%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.40 $0.00 $-207K -
2017 $-3.73 $0.00 $-1.85M -
2018 $-4.14 $57.76K $-10.53M -18228.4%
2019 $-2.85 $2.36M $-9.77M -413.8%
2020 $-2.17 $7.91M $-10.17M -128.6%
2021 $-1.80 $9.5M $-11.23M -118.3%
2022 $-1.20 $20.15M $-7.54M -37.4%
2023 $-0.61 $26.34M $-5.07M -19.2%
2024 $-2.30 $35.8M $-22.55M -63%
2025 $-0.88 $35.85M $-9.87M -27.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message